Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (17)

2024

  1. Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators

    Journal of Prevention of Alzheimer's Disease

2022

  1. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism

    Neurobiology of Disease, Vol. 167

  2. Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease

    Journal of Alzheimer's disease : JAD, Vol. 90, Núm. 2, pp. 719-726

2021

  1. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

    International Journal of Geriatric Psychiatry, Vol. 36, Núm. 2, pp. 324-333

2019

  1. Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: A cross-sectional analysis from the AB255 Study

    Alzheimer's Research and Therapy, Vol. 11, Núm. 1

2015

  1. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: A longitudinal in-vivo study

    Neurobiology of Disease, Vol. 77, pp. 165-172

2014

  1. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: A two-step process

    Brain, Vol. 137, Núm. 8, pp. 2356-2367

  2. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes

    Neurobiology of Aging, Vol. 35, Núm. 11, pp. 2657.e13-2657.e19

2012

  1. Decreased carbon-11-flumazenil binding in early Alzheimer's disease

    Brain, Vol. 135, Núm. 9, pp. 2817-2825

  2. Usefulness of positron emission tomography with fludeoxyglucose F 18 and with carbon 11-tagged methionine in the diagnosis of hippocampal lesions

    Archives of Neurology, Vol. 69, Núm. 12, pp. 1652-1653

2011

  1. Functional bold MRI: Advantages of the 3 T vs. the 1.5 T

    Clinical Imaging, Vol. 35, Núm. 3, pp. 236-241

  2. Statistical parametric maps of 18F-FDG PET and 3-D autoradiography in the rat brain: A cross-validation study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, Núm. 12, pp. 2228-2237

2010

  1. Brain glucose metabolism in vascular white matter disease with dementia: Differentiation from Alzheimer disease

    Stroke, Vol. 41, Núm. 12, pp. 2889-2893

  2. Neuroimagen: Fundamentos técnicos y prácticos

    Revista Espanola de Medicina Nuclear, Vol. 29, Núm. 4, pp. 189-210

2009

  1. 5′-upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration

    Neurobiology of Disease, Vol. 33, Núm. 2, pp. 164-170

  2. New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification

    NeuroImage, Vol. 47, Núm. 2, pp. 533-539

2008

  1. Successful thalamic deep brain stimulation for orthostatic tremor

    Movement Disorders, Vol. 23, Núm. 13, pp. 1808-1811